TP53 and myeloproliferative disorder: We present evidence that this MPN arises as a consequence of a combination of three effects caused by low Gfi1 expression (Fig. 8): a myeloid differentiation arrest with accumulation of myeloid cells; altered metabolic activity leading to elevated ROS levels and reduced ability to activate a p53 cell death pathway upon stress signals.